4.7 Article

Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing

期刊

PHARMACEUTICS
卷 14, 期 5, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics14051058

关键词

co-processing; crystallization; fluidized bed coating; formulation; isolation-free manufacturing; pharmaceuticals

资金

  1. Irish Research Council Government of Ireland Postgraduate Research Scholarship [GOPI/2017/1980]
  2. SFI through the SSPC The SFI Research Centre for Pharmaceuticals
  3. European Regional Development Fund [12/RC/2275_P2]

向作者/读者索取更多资源

Integrated API and drug product processing allows molecules with high clinical efficacy but poor physicochemical characteristics to be commercialized by co-processing with excipients. The goal of this study was to purify a model API and impurity system and directly process it into a solid-state formulation without isolating a solid API phase. Confined agitated bed crystallization was used to purify the impure API and the spray coating process was developed using a Design of Experiments approach to control drug loading efficiency and crystallinity.
Integrated API and drug product processing enable molecules with high clinical efficacy but poor physicochemical characteristics to be commercialized by direct co-processing with excipients to produce advanced multicomponent intermediates. Furthermore, developing isolation-free frameworks would enable end-to-end continuous processing of drugs. The aim of this work was to purify a model API (sodium ibuprofen) and impurity (ibuprofen ethyl ester) system and then directly process it into a solid-state formulation without isolating a solid API phase. Confined agitated bed crystallization is proposed to purify a liquid stream of impure API from 4% to 0.2% w/w impurity content through periodic or parallelized operations. This stream is combined with a polymer solution in an intermediary tank, enabling the API to be spray coated directly onto microcrystalline cellulose beads. The spray coating process was developed using a Design of Experiments approach, allowing control over the drug loading efficiency and the crystallinity of the API on the beads by altering the process parameters. The DoE study indicated that the solvent volume was the dominant factor controlling the drug loading efficiency, while a combination of factors influenced the crystallinity. The products from the fluidized bed are ideal for processing into final drug products and can subsequently be coated to control drug release.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据